In a significant move, General Motors has laid off around 1,700 workers at its Michigan and Ohio plants due to a slowdown in the electric vehicle market. The company aims to realign its EV capacity amid evolving regulations and declining consumer incentives.
In a strategic effort to challenge China's grip on rare earths, Trump has signed several agreements in Asia, aiming to diversify supply chains and reduce dependency on Beijing. As the US enters critical negotiations with Xi Jinping, the ramifications of these deals could reshape global manufacturing and trade dynamics.
China's ambitions for its C919 passenger jet are stalling as production falls short of targets amid trade tensions with the U.S. and reliance on Western components. Can it ever rival Boeing and Airbus?
The EU has imposed new economic sanctions on Russia, targeting key sectors like oil and gas, amidst ongoing tensions over the Ukraine conflict. Ukrainian President Zelenskyy applauds the measures as crucial for peace.
In a significant decision, the FAA has lifted the production cap on Boeing's 737 Max jets from 38 to 42 per month, reflecting improved confidence in the company's manufacturing safety. This comes after a safety incident raised concerns about the aircraft's reliability.
Boeing plans to ramp up 737 production to 42 planes per month, aiming for financial recovery after years of debt. Enhanced FAA oversight ensures safety amid supply chain challenges.
As the U.S. pressures allies to curb Chinese influence in technology, the Dutch government seizes control of Nexperia, a major chip manufacturer. What does this mean for global supply chains?
The Canadian government is poised to take legal action against Stellantis as the car giant plans to move Jeep Compass production to the US, breaching a previous commitment.
In a significant announcement, President Trump is set to reveal a new drug pricing deal with AstraZeneca, following a similar agreement with Pfizer. This move aims to lower U.S. drug prices and pressure major drugmakers to bring manufacturing back to America. Will it lead to real savings for taxpayers?
In a groundbreaking announcement, President Trump reveals a deal with AstraZeneca to lower drug prices for Americans, especially low-income individuals. With a new website set to launch, this initiative aims to make prescriptions more accessible than ever.
